That is what Don would like you to believe.  But the market price is what it is...a verdict on the company's prospects...or rather lack of it.  

I think the lack of any communications whatsoever from RVX has been a debilitating influence.  This is a news driven stock...and with no news, markets automatically assume the worst.  Whatever happened to the kidney data?  And what about a deal?  Any potential partner can also see the share price and come to their own conclusion.  Now a buyout would the least painful way out...and I for one will be thrilled for ANY buyout price.